Douglas W Losordo, M.D., FSCAI

Caladrius Biosciences
Rye Brook, NY
USA

Papers:

Significant reduction in mortality following single administration of autologous CD34 cells in the orphan indication of No-Option Refractory Disabling Angina (NORDA): Re-analysis of the largest completed study of CD34 cell therapy